Machine Learning-Based Survival Prediction Tool for Adrenocortical Carcinoma
Emre Sedar Saygili1,2, Yasir S Elhassan2,3, Alessandro Prete2,4,3,5
1Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Canakkale Onsekiz Mart University, Canakkale 17020, Turkey.
The Journal of Clinical Endocrinology and Metabolism
|February 14, 2025
Summary
Machine learning models enhance the S-GRAS score for predicting outcomes in adrenocortical carcinoma (ACC). This approach improves prognostic classification and provides an accessible web tool for personalized patient management.
Area of Science:
- Oncology
- Medical Informatics
- Biostatistics
Background:
- Adrenocortical carcinoma (ACC) is a rare and aggressive cancer with unpredictable outcomes.
- The S-GRAS score, combining clinical and histopathological factors, offers good prognostic value for ACC patients.
Purpose of the Study:
- To enhance prognostic classification for ACC by developing advanced machine learning (ML) models.
- To create an individualized risk prediction tool for ACC patients.
Main Methods:
- Developed and validated ML models using a large training cohort (n=942) and an independent validation cohort (n=152).
- Constructed sixteen ML models based on individual clinical variables from the S-GRAS dataset.
- Developed a web-based tool for accessible, individualized risk prediction.
Main Results:
- Top-performing ML models (Quadratic Discriminant Analysis, Light Gradient Boosting Machine, AdaBoost Classifier) accurately predicted 5-year overall mortality and 1- and 3-year disease progression.
- Achieved high F1 scores in both training and validation cohorts for key prognostic endpoints.
- The developed web tool provides instant risk estimation for mortality and disease progression.
Conclusions:
- S-GRAS parameters are effective for predicting ACC outcomes when utilized with robust ML models.
- The accessible web application facilitates personalized management decisions for ACC patients by providing instant risk assessments.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321
Comparing the Survival Analysis of Two or More Groups
122
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
122
Kaplan-Meier Approach
79
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
79


